This conversation took place at ASPEN Clinical Nutrition Week 2015 and was moderated by Robert Martindale, MD. In this video segment, he discusses the question, can over-supplementation of specialized pro-resolving mediators (SPMs) lead to pathway down-regulation. The conversation took place with Dr. Stephen McClave, Dr. Jesmond Dalli, and Dr. Todd Rice. The conversation is part of a series on inflammation entitled, Inflammation: Should we Block or Accelerate Its Resolution?
Dr. Martindale asks if the body might down-regulate the production of specialized pro-resolving mediators. Dr. Dalli replies that there are many ways for the body to remove the molecules, so the evidence suggests that the body will not down-regulate the production of SPMs.
Roundtable Symposia from ASPEN Clinical Nutrition Week 2015
Participating Speakers are:
Robert G. Martindale, MD, PhD
Stephen McClave, MD
Jesmond Dalli, PhD
Todd Rice, MD
